Sinotherapeutics (SH:688247) Zheng Quan Zhi Xing·2025-09-05 08:09Core Viewpoint - The company will participate in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry on September 15, 2025, to address investor concerns and discuss its operational results and financial status for the first half of 2025 [1][2]. Group 1: Meeting Details - The meeting is scheduled for September 15, 2025, from 15:00 to 17:00 [2][3]. - The location of the meeting is the Shanghai Stock Exchange Roadshow Center, accessible via the website: http://roadshow.sseinfo.com/ [2][3]. - The format of the meeting will be an online interactive session [2][3]. Group 2: Participation Information - Investors can participate in the meeting by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [3]. - Investors are encouraged to submit questions from September 8 to September 12, 2025, before 16:00, either through the Roadshow Center's "Pre-Question Collection" section or via the company's email [3]. - The company will respond to commonly asked questions during the briefing [3]. Group 3: Attendees - Key attendees include the Chairman Ye Jun, General Manager Guo Mingjie, Vice General Manager and Financial Officer Wu Yiming, Vice General Manager and Board Secretary Li Fangli, and Independent Director Liu Zhijie [2].